Pfizer

Paper Summary:

This paper explains that Pfizer is a multi-billion dollar pharmaceutical company that produces and distributes several blockbuster pharmaceutical products. It claims that currently the world's leading pharmaceutical product is Lipitor, one of Pfizer's products. Lipitor has been the target of several patent challenges and is scheduled to move off patent in any regard within the next several years. It explores how Pfizer will be affected by this and expands on its business plans.

From the Paper:

"Pfizer is a multi-billion dollar pharmaceutical company that produces and distributes several blockbuster pharmaceutical products. Currently the world's leading pharmaceutical product is Lipitor, one of Pfizer's products. Lipitor has been the target of several patent challenges and is scheduled to move off patent in any regard within the next several years. Pfizer is recommended to develop its own generic product, based on Lipitor, as a way to offset a percentage of the sales that are certain to be affected by other generic drug manufacturers. By developing this line extension of its blockbuster Lipitor product, Pfizer can continue to generate revenue off its substantial investment in research and development required for Lipitor without cannibalizing sales of its remaining Lipitor business."

More papers on Pfizer:

• Term Paper # 122442 : "Pfizer Inc."
• Term Paper # 133650 : "Pfizer's Organizational Growth"
• Essay # 73987 : "Pfizer's Marketing Strategy"
• Analytical Essay # 69458 : "Pfizer"

APA Citation:

MLA Citation: